Literature DB >> 12972911

Herpes simplex virus and Meniere's disease.

Jeffrey T Vrabec1.   

Abstract

OBJECTIVE/HYPOTHESIS: This study was designed to investigate the hypothesis that Meniere's disease is associated with herpes simplex virus (HSV) reactivation in the vestibular ganglion. STUDY
DESIGN: Case control study.
METHODS: Vestibular ganglia were obtained from archival surgical pathology specimens from patients undergoing vestibular neurectomy for vertigo caused by Meniere's disease. All patients met criteria for classification as definite Meniere's disease according to American Academy of Otolaryngology/Head and Neck Surgery (AAO-HNS) criteria. Control specimens were obtained from willed body donors. Sections from each ganglion were studied for prevalence of viral DNA using a nested polymerase chain reaction designed to amplify the HSV DNA polymerase gene. Quantitative analysis determined the number of viral copies per standard unit of ganglionic DNA.
RESULTS: HSV DNA was more prevalent in paraffin embedded ganglia from patients with Meniere's disease (100%) than in fresh-frozen control ganglia (81%) (P =.02). Fixation and paraffin embedding substantially reduced recovery of HSV virus in selected control specimens. Quantitative analysis found no correlation between viral copy number in control ganglia processed frozen versus formalin fixed and paraffin embedded.
CONCLUSIONS: HSV is more commonly isolated from vestibular ganglia of patients with Meniere's disease than the general population. The routine histologic preparation of formalin fixation and paraffin embedding significantly altered the quantity of virus detected though not in a predictable manner. The study provides supportive evidence for a viral etiology in Meniere's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972911     DOI: 10.1097/00005537-200309000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Sequence variants in host cell factor C1 are associated with Ménière's disease.

Authors:  Jeffrey T Vrabec; Liqian Liu; Bingshan Li; Suzanne M Leal
Journal:  Otol Neurotol       Date:  2008-06       Impact factor: 2.311

Review 2.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

3.  Intratympanic dexamethasone injections for refractory Meniere' s disease.

Authors:  Hongmiao Ren; Tuanfang Yin; Yongde Lu; Weijia Kong; Jihao Ren
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 4.  The Price of Immune Responses and the Role of Vitamin D in the Inner Ear.

Authors:  Béla Büki; Heinz Jünger; Yan Zhang; Yunxia Wang Lundberg
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.311

5.  Quantitative analysis of herpes simplex virus in cranial nerve ganglia.

Authors:  Jeffrey T Vrabec; Raye L Alford
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

6.  Altered chromogranin A circulating levels in Meniere's disease.

Authors:  Roberto Teggi; Barbara Colombo; Matteo Trimarchi; Mimma Bianco; Angelo Manfredi; Mario Bussi; Angelo Corti
Journal:  Dis Markers       Date:  2015-04-23       Impact factor: 3.434

7.  The role of cyclooxygenase in multiplication and reactivation of HSV-1 in vestibular ganglion neurons.

Authors:  Yuehong Liu; Shufeng Li; Zhengmin Wang
Journal:  ScientificWorldJournal       Date:  2014-02-05

Review 8.  The genetics of Ménière's disease.

Authors:  Giuseppe Chiarella; C Petrolo; E Cassandro
Journal:  Appl Clin Genet       Date:  2015-01-08

Review 9.  The aetiopathologies of Ménière's disease: a contemporary review.

Authors:  B S Oberman; V A Patel; S Cureoglu; H Isildak
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-08       Impact factor: 2.124

Review 10.  Viral causes of hearing loss: a review for hearing health professionals.

Authors:  Brandon E Cohen; Anne Durstenfeld; Pamela C Roehm
Journal:  Trends Hear       Date:  2014-07-29       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.